Three years ago, the High Court’s equal division in Aristocrat Technologies Australia Pty Ltd v Commissioner of Patents [2022] HCA 29 (reported here) left Australia without binding guidance on the patentability of computer implemented inventions.
Today, the High Court of Australia has dismissed an application for special leave to appeal from Aristocrat Technologies Australia Pty Ltd v Commissioner of Patents [2025] FCAFC 131.
Our IP lawyers combine deep legal expertise with technical and commercial understanding to help you protect, enforce and maximise the value of your IP assets.
Many of our clients make use of the Australian Designs system to protect the unique appearance of their products.
Our IP professionals understand, protect, help commercialise and defend hardware and software innovations so that our clients can thrive in fast-moving and highly competitive markets.
Australia’s life sciences ecosystem is experiencing sustained growth, driven by advances in biotechnology, digital health, precision medicine, agricultural innovation and materials science.
This policy explains how and why we collect, use, hold and disclose your personal information.
We are committed to improving our community. We do this through multiple pursuits, including providing pro-bono and discounted services to health-based organisations, supporting charities and supporting and educating our people on how they can assist those less fortunate.
The emergence of protein degraders, including proteolysis-targeting chimeras (PROTACs) and molecular glues, represents one of the most exciting shifts in drug discovery over the past 20 years.
Discover what it’s like to work with us, including employee benefits, career opportunities and pathways to becoming a patent attorney or lawyer.
